Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Medical Oncology
•
Hematology
•
Pediatric Hematology
•
Iron Homeostasis
•
Primary Care
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
Answer from: at Community Practice
Excellent article on this topic: Baskin-Miller et al., PMID 39096194
Sign in or Register to read more
26026
Related Questions
How is your experience with point-of-care INR systems for home monitoring of vitamin K antagonists?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
How do you approach the work-up for a patient with iron deficiency anemia who is not responding to oral iron therapy?
In pure red cell aplasia, does peripheral blood-positive IgG for parvovirus have significance if persistently positive on retesting, but IgM and PCR are negative?
Is it necessary to prescribe a steroid taper after two weeks of high-dose prednisone (60 mg daily)?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
What is your experience with managing patients with STEAP3 mutation and non-transfusion related iron overload?